Clinical Trial Update: Phase I Trial of Periocular Topotecan in Retinoblastoma [Phase 1]

View source ↗

Summary

Phase I trial evaluating periocular topotecan for retinoblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• Periocular Topotecan (topotecan)

Snippet

Sponsor: Hospital JP Garrahan | Conditions: Retinoblastoma | Phase 1 | Status: COMPLETED